Bausch Health Companies Investor Conference Presentation Deck
18
Reconciliation of Reported Revenue to Organic Revenue ¹,2 and
Organic Revenue Growth ¹,2 ($M) (Quarter-to-Date)4
Bauch +Lomb
4
Global Vision Care
Global Surgical
Global Consumerª
Global Ophtho Rx4
Total Bausch + Lomb
Bausch Pharma5
Salix
Salix
International Rx4
International Rx4
Ortho Dermatologics4
Ortho Dermatologics 4
Global Solta
Total Ortho Dermatologics
Diversified Products
Neurology & Otherª
Generics
Dentistry
Total Diversified Products
Total Bausch Pharm a revenues 5
Total Bausch Health revenues
BAUSCH- Health
Revenue
as
Reported
226
173
379
171
949
527
271
66
74
140
151
48
25
224
1,162
Calculation of Organic Revenue for the Three Months Ended
September 30, 2021
September 30, 2020
Changes in
Exchange
Rates ³
$ 2,111 $
(1)
(4)
(3)
(2)
(10)
(2)
(2)
(19)
$
Organic
Revenue
(Non-
GAAP) ¹,2
225
169
376
169
939
527
264
66
72
138
151
48
25
224
1,153
2,092
Revenue
as
Reported
214
151
351
200
916
496
308
70
73
143
200
56
19
275
1,222
$ 2,138
Divestitures and
Discontinuations
$
CE
(4)
(42)
(42)
(46) $
Organic
Revenue
(Non-
GAAP) ¹,2
213
150
350
199
912
496
266
70
73
143
200
56
19
275
1,180
Change in
Organic Revenue
Amount
2,092 $
12
19
26
(30)
27
31
(49)
(8)
6
(51)
Pct.
(27)
6%
13%
7%
-15%
3%
6%
(4) -6%
(1)
-1%
(5)
-3%
-1%
-25%
-14%
32%
-19%
-2%
0%
1. See Slide 2 and this Appendix for further non-GAAP information
2 Organic growth/change, a non-GAAP metric, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and
discontinuations.
3. The impact for changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current period reported
revenues revalued using the monthly average currency exchange rates during the comparable prior period.
4.
See footnote 3 at slide 6 for further details regarding the realigned segment reporting structure and the conformed prior period presentation.
5. Bausch Pharma revenues, a non-GAAP metric, are determined by subtracting Bausch+Lomb segment revenues for the applicable period from total Bausch Health revenues for the applicable period.View entire presentation